Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)

China flag China · Delayed Price · Currency is CNY
19.99
+0.25 (1.27%)
At close: Jul 31, 2026
Market Cap8.22B -29.9%
Revenue (ttm)1.31B -21.8%
Net Income57.66M -82.7%
EPS0.14 -82.3%
Shares Out 411.25M
PE Ratio140.07
Forward PE44.42
Dividend0.10 (0.50%)
Ex-Dividend DateJun 3, 2026
Volume1,874,282
Open19.76
Previous Close19.74
Day's Range19.76 - 20.04
52-Week Range18.91 - 29.63
Beta0.43
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About SHA:688739

Liaoning Chengda Biotechnology Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of vaccines in China and internationally. It offers inactivated Japanese encephalitis and SPEEDA-rabies vaccines. The company also develops rabies vaccine which is in new drug approval stage; influenza vaccine which is in new drug application stage; recombinant human papillomavirus 15-valent vaccine which is in Phase II clinical stage; and 13-valent pneumococcal polysaccharide conjugate, varicella, and meningococcal ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 1,781
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688739
Full Company Profile

Financial Performance

In 2025, SHA:688739's revenue was 1.39 billion, a decrease of -17.06% compared to the previous year's 1.68 billion. Earnings were 131.79 million, a decrease of -61.56%.

Financial Statements